• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pascal Soriot - Articles and news items

AstraZeneca

AstraZeneca PLC fourth quarter and full year results 2013

Industry news / 6 February 2014 / AstraZeneca

“As expected, our financial performance for 2013 reflects the ongoing impact from the loss of exclusivity for several key brands…”

AstraZeneca

AstraZeneca completes the acquisition of Bristol-Myers Squibb share of global diabetes alliance

Industry news / 3 February 2014 / AstraZeneca

AstraZeneca announced that it completed, on 1 February 2014, the acquisition of the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance…

AstraZeneca

AstraZeneca provides update at JP Morgan Healthcare Conference on progress to achieve scientific leadership and return to growth

Industry news / 14 January 2014 / AstraZeneca

At the conference, Pascal Soriot will provide an update on the company’s development pipeline and outline its strategic priorities for 2014…

AstraZeneca

AstraZeneca to acquire Bristol-Myers Squibb share of global diabetes alliance assets

Industry news / 19 December 2013 / AstraZeneca

Global agreement strengthens AstraZeneca’s commitment to diabetes, a key growth platform in a core strategic area for the company…

AstraZeneca

Marc Dunoyer appointed Chief Financial Officer of AstraZeneca

Industry news / 31 October 2013 / AstraZeneca

“Following a thorough and extensive search it became clear that Marc possessed the rare blend of financial, business and science experience…”

PharmaBio-Creative

FT Global Pharmaceutical and Biotechnology Conference

News, Supplier news / 6 August 2013 / Financial Times

3 – 4 December 2013, The InterContinental Park Lane, London…

AstraZeneca
AstraZeneca

Simon Lowth, Chief Financial Officer, to leave AstraZeneca

Industry news, News / 15 July 2013 / AstraZeneca

AstraZeneca announced that Simon Lowth, CFO and Executive Director, will leave the company at the end of October…

AstraZeneca

AstraZeneca selects location for new global R&D centre and corporate headquarters in Cambridge, UK

Industry news, News / 18 June 2013 / AstraZeneca

“AstraZeneca’s investment is excellent news for the UK life sciences industry…”

AstraZeneca

AstraZeneca to acquire Pearl Therapeutics to strengthen respiratory portfolio

Industry news, News / 10 June 2013 / AstraZeneca

AstraZeneca has entered into a definitive agreement to acquire Pearl Therapeutics…

AstraZeneca

AstraZeneca to acquire Omthera Pharmaceuticals

Industry news / 28 May 2013 / AstraZeneca

AstraZeneca announced that it has entered into a definitive agreement to acquire Omthera Pharmaceuticals…

AstraZeneca

AstraZeneca appoints Marc Dunoyer as Executive Vice President, Global Portfolio & Product Strategy

Industry news, News / 21 March 2013 / AstraZeneca

AstraZeneca announced that Marc Dunoyer is to join the company…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +